The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.75% between 2025 and ...
Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...
According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...
MiBolsilloColombia on MSN
Medicare drug price negotiation: 10 drugs cheaper in 2026
Big savings are coming in 2026. See the list of the first 10 drugs with prices negotiated by Medicare, including Eliquis, ...
The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
The Canadian Press on MSN
Novo Nordisk considers competing with generics through renamed lower-price Ozempic
Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback